Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis
Clinical trial NCT00770965 · COMPLETED
Trial details
- NCT number
- NCT00770965
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-10
- Primary completion
- 2009-09-17
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.